Demand grows for UK ministers to reclassify psilocybin for medical research
by Denis Campbell Health policy editor from Science | The Guardian on (#5WVSY)
People suffering debilitating cluster headaches say the active ingredient in magic mushrooms is a help
Conservative drug reformers and leading psychiatrists are urging ministers to reclassify the psychedelic compound psilocybin so that researchers can explore its potential as a medicine.
The same demand is being made by people suffering from cluster headaches - which involve severe pain that existing drugs do little to relieve - amid evidence that psilocybin can help reduce both the condition's physical and mental impact.
Continue reading...